Binance Square
#marijuana

marijuana

532 views
6 Discussing
L I A
·
--
Article
​🚀 Trump to Reschedule Marijuana TODAY: Market Alert! President Trump is expected to sign an Executive Order today moving marijuana to Schedule III. This is a massive "risk-on" signal for both TradFi and Crypto. Why the markets are pumping: ​Tax Winds: Eliminates the 280E tax, saving cannabis firms millions. 💸 ​Banking Boost: Clears the path for credit cards and traditional banking. 🏦 ​Crypto Synergy: Pro-innovation policy fuels the "Trump Trade" across $BTC and high-growth sectors. ​Market Reaction: Watch $TLRY, $CGC, and $MSOS for volatility. As federal restrictions ease, expect increased interest in RWA (Real World Asset) tokens and payment-focused cryptos. ​🌿 Is this the start of the "Green Bull" run? ​👇 Drop your watch list below! Are you buying the news? ​#TRUMP #Marijuana #CryptoNews #bitcoin #TradingSignals

​🚀 Trump to Reschedule Marijuana TODAY: Market Alert!

President Trump is expected to sign an Executive Order today moving marijuana to Schedule III. This is a massive "risk-on" signal for both TradFi and Crypto.
Why the markets are pumping:
​Tax Winds: Eliminates the 280E tax, saving cannabis firms millions. 💸
​Banking Boost: Clears the path for credit cards and traditional banking. 🏦
​Crypto Synergy: Pro-innovation policy fuels the "Trump Trade" across $BTC and high-growth sectors.
​Market Reaction:
Watch $TLRY, $CGC, and $MSOS for volatility. As federal restrictions ease, expect increased interest in RWA (Real World Asset) tokens and payment-focused cryptos.
​🌿 Is this the start of the "Green Bull" run?
​👇 Drop your watch list below! Are you buying the news?

#TRUMP #Marijuana #CryptoNews #bitcoin #TradingSignals
Article
Major cannabis stocks surge Friday after reports Trump is expected to sign executive order Major cannabis stocks surge Friday after reports Trump is expected to sign executive order to reclassify marijuana. Stock Performance Highlights Canopy Growth (WEED: TSE) shares jumped more than 50% in single-day trading on Friday, closing at $2.40 CAD per share, up significantly from its previous close of $1.57 CAD. Tilray Brands (TLRY: NASDAQ) stock climbed over 55%, closing at $12.15 USD. Its shares added another 11% in after-hours trading. Aurora Cannabis (ACB: TSE) stock rose nearly 17%, closing at $7.44 CAD per share. Industry Impact The potential reclassification of cannabis from a Schedule I to a Schedule III drug would represent a significant shift in U.S. federal policy, acknowledging its medical use and lowering its perceived potential for abuse. This regulatory change could ease several burdens for cannabis companies, including: Tax relief: It would likely alleviate some of the heavy tax burdens currently faced by cannabis businesses. Banking access: It could facilitate easier access to mainstream banking services and capital from lenders and investors. Research opportunities: The change would bolster opportunities for medical research into cannabis. The news triggered broad gains across the sector, with the CNBS cannabis ETF and the Amplify Alternative Harvest ETF (MJ) also recording their best single-day performances ever. We can track the performance of these and other cannabis stocks as the potential executive order unfolds. Would you like to focus on the impact on a specific company's financials, such as Canopy Growth's revenue or net income? #Marijuana #pot #Canopy #Tilray #Cannabis

Major cannabis stocks surge Friday after reports Trump is expected to sign executive order

Major cannabis stocks surge Friday after reports Trump is expected to sign executive order to reclassify marijuana.

Stock Performance Highlights
Canopy Growth (WEED: TSE) shares jumped more than 50% in single-day trading on Friday, closing at $2.40 CAD per share, up significantly from its previous close of $1.57 CAD.
Tilray Brands (TLRY: NASDAQ) stock climbed over 55%, closing at $12.15 USD. Its shares added another 11% in after-hours trading.
Aurora Cannabis (ACB: TSE) stock rose nearly 17%, closing at $7.44 CAD per share.

Industry Impact
The potential reclassification of cannabis from a Schedule I to a Schedule III drug would represent a significant shift in U.S. federal policy, acknowledging its medical use and lowering its perceived potential for abuse.
This regulatory change could ease several burdens for cannabis companies, including:
Tax relief: It would likely alleviate some of the heavy tax burdens currently faced by cannabis businesses.
Banking access: It could facilitate easier access to mainstream banking services and capital from lenders and investors.
Research opportunities: The change would bolster opportunities for medical research into cannabis.
The news triggered broad gains across the sector, with the CNBS cannabis ETF and the Amplify Alternative Harvest ETF (MJ) also recording their best single-day performances ever.
We can track the performance of these and other cannabis stocks as the potential executive order unfolds. Would you like to focus on the impact on a specific company's financials, such as Canopy Growth's revenue or net income?

#Marijuana #pot #Canopy #Tilray #Cannabis
Login to explore more contents
Join global crypto users on Binance Square
⚡️ Get latest and useful information about crypto.
💬 Trusted by the world’s largest crypto exchange.
👍 Discover real insights from verified creators.
Email / Phone number